Suchergebnisse - (Subject:"Siltuximab")

PubPharm (121)

31

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome

enthalten in: International journal of medical sciences | 2021

von Du, P. | Geng, J. | Wang, F. | +3

32

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

enthalten in: American journal of hematology | 2020

von Fajgenbaum, D. | Wu, D. | Goodman, A. | +21

33

Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease

enthalten in: Expert opinion on investigational drugs | 2020

von Zhou, Z. | Price, C.

34

Frontline Siltuximab and Rituximab in TAFRO syndrome : A case report

enthalten in: European journal of haematology | 2020

von Marchetti, M. | Feyles, E. | Zinzani, P.

35

Involvement of interleukin 6 in SARS-CoV-2 infection : siltuximab as a therapeutic option against COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2020

von Palanques-Pastor, T. | López-Briz, E. | Poveda Andrés, J.

36

Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques

enthalten in: Artificial organs | 2020

von Swol, J. | Lorusso, R.

37

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19 : Rationale, Clinical Evidence and Risks

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2020

von Crisafulli, S. | Isgrò, V. | La Corte, L. | +2

38

A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients

enthalten in: European review for medical and pharmacological sciences | 2020

von Solis-García Del Pozo, J. | Galindo, M. | Nava, E. | +1

39

Cytokine storm intervention in the early stages of COVID-19 pneumonia

enthalten in: Cytokine & growth factor reviews | 2020

von Sun, X. | Wang, T. | Cai, D. | +9

CommentIn: Cytokine Growth Factor Rev. 2021 Apr;58:30-31. - PMID 32873506

40

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID) : A structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Maes, B. | Bosteels, C. | De Leeuw, E. | +14

ErratumIn: Trials. 2020 Jun 22;21(1):556. - PMID 32571394